Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers.

Cancer - 15 Mar 2013

Cott Chubiz Jessica E, Lee Janie M, Gilmore Michael E, Kong Chung Y, Lowry Kathryn P, Halpern Elkan F, McMahon Pamela M, Ryan Paula D, Gazelle G Scott

Abstract excerpt

BACKGROUND: Current clinical guidelines recommend earlier, more intensive breast cancer screening with both magnetic resonance imaging (MRI) and mammography for women with breast cancer susceptibility gene (BRCA) mutations. Unspecified details of screening schedules are a challenge for implementing guidelines. METHODS: A Markov Monte Carlo computer model was used to simulate screening in asymptomatic women who...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cost-Benefit Analysis
Share to Early Detection of Cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Magnetic Resonance Imaging

Share to Mammography

Share to Monte Carlo Method

Share to Quality-Adjusted Life Years

Source

Open in PubMed Open full text

Identifiers

PMID: 23184400
DOI: 10.1002/cncr.27864
PMCID: PMC3586945

Genes

BRCA2
BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers.PMID 23184400Read ↗

Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysis.Semantic proximity Read ↗

Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.Semantic proximity Read ↗

Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers.Semantic proximity Read ↗

Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers.Semantic proximity Read ↗

The cost-utility of magnetic resonance imaging for breast cancer in BRCA1 mutation carriers aged 30-49.Semantic proximity Read ↗

Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk.Semantic proximity Read ↗

Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers.Semantic proximity Read ↗

Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined.Semantic proximity Read ↗

Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer.Semantic proximity Read ↗

Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers.Semantic proximity Read ↗

Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.Semantic proximity Read ↗

The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.